Boehringer Ingelheim Launches Metalyse® 25 mg in Egypt Following Approval by the Egyptian Drug Authority
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has announced the introduction of…
Boehringer Ingelheim partners with General Organization of Veterinary Services to ‘Stop Rabies’ in Egypt
In a first-of-its-kind public-private partnership, the General Organization of Veterinary Services (GOVS)…